You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

daratumumab

Showing 1 - 25 of 153
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stem Cells Mobilization, colLection and Engraftment in Newly

Recruiting
  • Multiple Myeloma
  • +3 more
  • Daratumumab
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Aplastic Anemia, Platelet Transfusion Refractoriness Trial in Tianjin (Daratumumab)

Recruiting
  • Aplastic Anemia
  • Platelet Transfusion Refractoriness
  • Daratumumab
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Apr 25, 2023

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 10, 2023

Acquired Hemophilia Trial in Tianjin (Daratumumab)

Recruiting
  • Acquired Hemophilia
  • Daratumumab
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
May 5, 2023

Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in Miami (Iberdomide, Carfilzomib, Daratumumab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • Relapsed Multiple Myeloma
  • Miami, Florida
    University of Miami
May 31, 2023

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +10 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Glioblastoma Trial in Morgantown (Daratumumab)

Recruiting
  • Glioblastoma
  • Daratumumab
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
Dec 5, 2022

Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

Not yet recruiting
  • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic Minnesota
Dec 8, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Jan 9, 2023

Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)

Completed
Has Results
  • Multiple Myeloma
  • Antwerpen, Belgium
  • +12 more
Dec 1, 2022

Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Multiple Myeloma Trial in Rochester (procedure, biological, drug)

Not yet recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +12 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 15, 2023

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)

Recruiting
  • Neuromyelitis Optica
  • +2 more
  • Daratumumab
  • Placebo
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Oct 19, 2022

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (Daratumumab, Clarithromycin,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
Jun 8, 2022

Multiple Myeloma Trial in Cologne (Daratumumab)

Recruiting
  • Multiple Myeloma
  • Daratumumab
  • Cologne, Germany
    University of Cologne
Apr 4, 2022

Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • Daratumumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • daratumumab
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 28, 2022

Lupus Nephritis Trial in Rochester (Daratumumab)

Recruiting
  • Lupus Nephritis
  • Daratumumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 23, 2022

Multiple Myeloma Trial (Teclistamab, Daratumumab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 6, 2022

Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)

Recruiting
  • Multiple Myeloma
  • Daratumumab
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center
Jun 10, 2022

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Daratumumab
  • +5 more
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • Daratumumab
  • +4 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022